PL2436672T3 - Środek przeciwwstrząsowy zawierający pochodną diaminotrifluorometylopirydyny - Google Patents
Środek przeciwwstrząsowy zawierający pochodną diaminotrifluorometylopirydynyInfo
- Publication number
- PL2436672T3 PL2436672T3 PL10780439T PL10780439T PL2436672T3 PL 2436672 T3 PL2436672 T3 PL 2436672T3 PL 10780439 T PL10780439 T PL 10780439T PL 10780439 T PL10780439 T PL 10780439T PL 2436672 T3 PL2436672 T3 PL 2436672T3
- Authority
- PL
- Poland
- Prior art keywords
- shock agent
- diaminotrifluoromethylpyridine derivative
- diaminotrifluoromethylpyridine
- derivative
- shock
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009129578 | 2009-05-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2436672T3 true PL2436672T3 (pl) | 2017-09-29 |
Family
ID=43222595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10780439T PL2436672T3 (pl) | 2009-05-28 | 2010-05-17 | Środek przeciwwstrząsowy zawierający pochodną diaminotrifluorometylopirydyny |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8604212B2 (pl) |
| EP (1) | EP2436672B1 (pl) |
| JP (1) | JP5584518B2 (pl) |
| CA (1) | CA2761597C (pl) |
| ES (1) | ES2629428T3 (pl) |
| HU (1) | HUE033310T2 (pl) |
| PL (1) | PL2436672T3 (pl) |
| PT (1) | PT2436672T (pl) |
| WO (1) | WO2010137484A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2020117897A (ru) * | 2017-11-02 | 2021-12-02 | Исихара Сангио Кайся, Лтд. | Фармацевтическая композиция замедленного высвобождения |
| KR20200127222A (ko) | 2018-03-01 | 2020-11-10 | 이시하라 산교 가부시끼가이샤 | 보존 안정성이 우수한 의약 조성물 |
| WO2020230876A1 (ja) | 2019-05-15 | 2020-11-19 | 石原産業株式会社 | Ｎ－（２－エチルスルホニルアミノ－５－トリフルオロメチル－３－ピリジル）シクロヘキサンカルボキサミド・一ナトリウム塩の無水和物結晶体 |
| AU2021354445A1 (en) | 2020-09-29 | 2023-05-18 | Ishihara Sangyo Kaisha, Ltd. | Liquid pharmaceutical composition demonstrating excellent preservation efficacy |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5260320A (en) | 1990-07-10 | 1993-11-09 | Ishihara Sangyo Kaisha Ltd. | Diaminotrifluoromethylpyridine compounds and phospholipase A2 inhibitor containing them |
| EP0465913B1 (en) * | 1990-07-10 | 1997-09-10 | Ishihara Sangyo Kaisha, Ltd. | Diaminotrifluoromethylpyrimidine derivatives, process for their production and phospholipase A2 inhibitor containing them |
| ZA915023B (en) | 1990-07-10 | 1992-05-27 | Ishihara Sangyo Kaisha | Diaminotrifluoromethylpyridine derivatives,process for their production and phospholipase a2 inhibitor containing them |
| JPH05170742A (ja) * | 1991-05-24 | 1993-07-09 | Ishihara Sangyo Kaisha Ltd | ジアミノトリフルオロメチルピリジン誘導体、それらの製造方法及びそれらを含有するホスホリパーゼ▲ａ２▼阻害剤 |
| JPH06135934A (ja) * | 1991-12-27 | 1994-05-17 | Ishihara Sangyo Kaisha Ltd | ピリジン誘導体又はその塩を含有するホスホリパーゼ▲ａ２▼阻害剤、抗炎症剤又は抗膵炎剤 |
| KR19990035780A (ko) | 1995-07-24 | 1999-05-25 | 후지야마 아키라 | Ｐｌａ２ 억제제로서의 에스테르 및 아미드 |
| TW415843B (en) | 1997-02-28 | 2000-12-21 | Ishihara Sangyo Kaisha | Anti-cancer pharmaceutical compositions comprising a diaminotrifluoromethylpyridine derivatives or the pharmaceutically acceptable salts thereof |
| US6653333B2 (en) | 2000-01-31 | 2003-11-25 | Ishihara Sangyo Kaisha, Ltd. | Remedies or preventives for digestive diseases containing diaminotrifluoromethylpyridine derivatives |
| JP4848092B2 (ja) | 2000-02-01 | 2011-12-28 | 石原産業株式会社 | ジアミノトリフルオロメチルピリジン誘導体を含有する肺不全の治療剤又は予防剤 |
| DE60113808T2 (de) | 2000-02-01 | 2006-05-18 | Ishihara Sangyo Kaisha Ltd. | Therapeutikum oder Prophylaktikum für Lebererkrankungen, enthaltend ein Diaminotrifluorethylpyridin-Derivat |
| CA2413582A1 (en) * | 2000-07-14 | 2002-01-24 | Eli Lilly And Company | Use of a spla2 inhibitor for the treatment of sepsis |
| US20040110825A1 (en) | 2001-06-29 | 2004-06-10 | Andrew Loh | Method for treating sepsis |
| WO2007074860A1 (ja) | 2005-12-28 | 2007-07-05 | Sekisui Medical Co., Ltd. | 凝集測定用試薬及び凝集測定方法 |
| JP2009129578A (ja) | 2007-11-20 | 2009-06-11 | K-One Create Corp | 棚板用の照明構造 |
-
2010
- 2010-05-13 JP JP2010110765A patent/JP5584518B2/ja active Active
- 2010-05-17 PT PT107804395T patent/PT2436672T/pt unknown
- 2010-05-17 HU HUE10780439A patent/HUE033310T2/en unknown
- 2010-05-17 WO PCT/JP2010/058310 patent/WO2010137484A1/ja active Application Filing
- 2010-05-17 EP EP10780439.5A patent/EP2436672B1/en active Active
- 2010-05-17 CA CA2761597A patent/CA2761597C/en active Active
- 2010-05-17 ES ES10780439.5T patent/ES2629428T3/es active Active
- 2010-05-17 US US13/320,570 patent/US8604212B2/en active Active
- 2010-05-17 PL PL10780439T patent/PL2436672T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2761597A1 (en) | 2010-12-02 |
| WO2010137484A1 (ja) | 2010-12-02 |
| ES2629428T3 (es) | 2017-08-09 |
| CA2761597C (en) | 2016-12-20 |
| US20120059039A1 (en) | 2012-03-08 |
| EP2436672A1 (en) | 2012-04-04 |
| JP2011006384A (ja) | 2011-01-13 |
| US8604212B2 (en) | 2013-12-10 |
| PT2436672T (pt) | 2017-05-30 |
| HUE033310T2 (en) | 2017-11-28 |
| EP2436672A4 (en) | 2012-11-28 |
| JP5584518B2 (ja) | 2014-09-03 |
| EP2436672B1 (en) | 2017-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2420493A4 (en) | HALOALKYLSULFONANILIDE DERIVATIVES | |
| HK1173142A1 (en) | N1-sulfonyl-5-fluoropyrimidinone derivatives n1--5- | |
| HK1172893A1 (en) | 5-fluoropyrimidinone derivatives 5- | |
| EP2412708A4 (en) | SUBSTITUTED 3-HYDROXY-4-PYRIDONE DERIVATIVE | |
| EP2514747A4 (en) | SUBSTITUTED AMINOTHIAZINE DERIVATIVE | |
| EP2397480A4 (en) | DIAZEPINEDIONE DERIVATIVE | |
| PT2433940E (pt) | Derivado de espiroimidazolona | |
| IL216007A0 (en) | Isoxazole-pyridine derivatives | |
| IL220526A0 (en) | Kokumi-imparting agent | |
| EP2478768A4 (en) | ANTIPHYTOVIRAL AGENT | |
| IL215109A0 (en) | Isoxazole-pyridazine derivatives | |
| IL214941A0 (en) | Isoxazole-pyrazole derivatives | |
| IL220527A0 (en) | Kokumi-imparting agent | |
| EP2407165A4 (en) | ANTIOXIDANTS | |
| IL213927A0 (en) | Deoxyactagardine derivatives | |
| EP2401281A4 (en) | PYRIMIDINPYRIMIDOINDAZOLDERIVAT | |
| HK1172894A1 (en) | N1-acyl-5-fluoropyrimidinone derivatives n1--5- | |
| HK1169623A1 (en) | Pyrazinooxazepine derivatives | |
| HK1174621A1 (en) | 5-hydroxypyrimidine-4-carboxamide derivative 5--4- | |
| EP2433502A4 (en) | AGENT FOR REMOVING AMERTUME | |
| EP2476682A4 (en) | 8-oxodihydropurine DERIVATIVE | |
| EP2463290A4 (en) | THIENOXAZEPINDERIVAT | |
| EP2436672A4 (en) | ANTI-CHOCK AGENT COMPRISING A DIAMINOTRIFLUOROMETHYLPYRIDINE DERIVATIVE | |
| EP2512482A4 (en) | DERIVATIVES OF 2-ALDOXIMINO-5-FLUOROPYRIMIDINE | |
| EP2492269A4 (en) | aminothiazole |